Artielle ImmunoTherapeutics
1 clinical trials · Sponsor
◉ Watch Artielle ImmunoTherapeutics
| Record | Firm | Date |
|---|---|---|
| Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis (NCT00411723) | Artielle ImmunoTherapeutics | 2006-12-01 |
Track Artielle ImmunoTherapeutics automatically
Every clearance here is in the API, with alerts when new ones post.